In one paragraphArticle in bioRxiv : the preprint server for biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
9 authors.
Shuqi YunCenter for Genomic Medicine, Massachusetts General Hospital Research Institute, Boston, MA, USA.ORCID 0009-0006-2228-6515 Anil ChekuriCenter for Genomic Medicine, Massachusetts General Hospital Research Institute, Boston, MA, USA.ORCID 0000-0002-0652-2630 Krishnakanth KondaboluCenter for Genomic Medicine, Massachusetts General Hospital Research Institute, Boston, MA, USA.
Susan A SlaugenhauptCenter for Genomic Medicine, Massachusetts General Hospital Research Institute, Boston, MA, USA.
Nadja ZeltnerCenter for Molecular Medicine, University of Georgia, Athens, GA, USA.
Benjamin P KleinstiverCenter for Genomic Medicine, Massachusetts General Hospital Research Institute, Boston, MA, USA.ORCID 0000-0002-5469-0655 Elisabetta MoriniCenter for Genomic Medicine, Massachusetts General Hospital Research Institute, Boston, MA, USA.ORCID 0000-0002-1658-5213 Christiano R R AlvesCenter for Genomic Medicine, Massachusetts General Hospital Research Institute, Boston, MA, USA.ORCID 0000-0002-2646-9689 Funding
PROJECT 4: Somatic evolution of the hematopoietic system in cardiovascular diseaseP01HL142494 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI Benjamin Peter Kleinstiver · 2019 to 2026
$19.5MModeling and Therapeutic Approaches for Genetic VasculopathiesR01NS125353 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI MARK E LINDSAY, Patricia L Musolino · 2022 to 2026
$3.5MScalable Development of Custom Genome Editing TechnologiesDP2CA281401 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI KLEINSTIVER, BENJAMIN PETER · 2022 to 2025
$2.5MUnderstanding Neuronal Cell type-Specific Dysregulation in Familial DysautonomiaR01NS095640 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI Elisabetta Morini, Susan A Slaugenhaupt · 2024 to 2026
$1.9MDeveloping Splicing-Targeted Therapeutic Strategies for Neurological DiseasesR01NS124561 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI MORINI, ELISABETTA, TELO BAPTISTA LIMA DA SILVA, MARIA CATARINA · 2022 to 2025
$1.7MDevelopment of in Vivo Base Editing as a Genetic Treatment for Spinal Muscular AtrophyK01NS134784 · NINDS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Christiano Alves · 2024 to 2026
$726kA one and done therapeutic strategy to correct ELP1 splicing defect in familial dysautonomiaR21EY037018 · NEI · MASSACHUSETTS GENERAL HOSPITAL · PI Christiano Alves, Elisabetta Morini · 2025 to 2026
$454kNCI NIH HHS DP2 CA281401NEI NIH HHS R21 EY037018NHLBI NIH HHS P01 HL142494NINDS NIH HHS K01 NS134784NINDS NIH HHS R01 NS095640NINDS NIH HHS R01 NS124561NINDS NIH HHS R01 NS125353
6 · The paper itselfAbstract
Familial dysautonomia (FD) is a fatal autosomal recessive congenital neuropathy caused by a T-to-C mutation in intron 20 of the
Indexed as
bystander editingCas9CRISPRELP1genome editingneurodegenerative diseasesplicing
Identifiers
PMID39651221
PMCPMC11623606
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390